BCL2L1 and breast carcinoma: Analysis of reverse-phase protein array (RPPA) data of human basal-like breast cancer samples from The Cancer Genome Atlas revealed that BCL-XL expression was correlated with KRAS and with phosphorylation levels of c-RAF at S338 that mark RAS activation (Fig. 3e).